Charlotte Kvasnovsky to Antitubercular Agents
This is a "connection" page, showing publications Charlotte Kvasnovsky has written about Antitubercular Agents.
Connection Strength
1.808
-
Extensively drug-resistant TB in Eastern Cape, South Africa: high mortality in HIV-negative and HIV-positive patients. J Acquir Immune Defic Syndr. 2011 Jun 01; 57(2):146-52.
Score: 0.393
-
Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study. Lancet. 2010 May 22; 375(9728):1798-807.
Score: 0.366
-
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet. 2018 09 08; 392(10150):821-834.
Score: 0.163
-
Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study. Lancet Infect Dis. 2017 07; 17(7):707-715.
Score: 0.148
-
Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study. PLoS Med. 2015 Dec; 12(12):e1001932.
Score: 0.135
-
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance. Clin Infect Dis. 2016 Feb 15; 62(4):418-430.
Score: 0.133
-
Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countries. Emerg Infect Dis. 2015 Jun; 21(6):977-83.
Score: 0.130
-
Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis. Clin Infect Dis. 2014 Oct 15; 59(8):1049-63.
Score: 0.122
-
Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection. Emerg Infect Dis. 2013 Mar; 19(3):416-24.
Score: 0.111
-
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study. Lancet. 2012 Oct 20; 380(9851):1406-17.
Score: 0.107